Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Sulena Shrestha"'
Autor:
Shreekant Parasuraman, Jingbo Yu, Dilan Paranagama, Sulena Shrestha, Li Wang, Onur Baser, Robyn Scherber
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Polycythemia vera (PV) is a myeloproliferative neoplasm associated with increased thrombotic and cardiovascular risk, which are key contributors to patient morbidity and mortality. The Veterans Health Administration (VHA) is the l
Externí odkaz:
https://doaj.org/article/d4c123255d1b493b9949bd44b6a8b92d
Autor:
Li Wang, Onur Baser, Robyn M. Scherber, Jingbo Yu, Sulena Shrestha, Shreekant Parasuraman, Dilan Paranagama
Publikováno v:
Annals of Hematology
Patients with polycythemia vera (PV) have a high incidence of thrombotic events (TEs), contributing to a greater mortality risk than the general population. The relationship between hematocrit (HCT) levels and TE occurrence among patients with PV fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90db9ffbde8efca69caf4ba47fad8d3b
https://doi.org/10.1007/s00277-019-03793-w
https://doi.org/10.1007/s00277-019-03793-w
Autor:
Li Wang, Ingolf Griebsch, Carl Samuelsen, Amanda K. Golembesky, Jonathan Lim, Sulena Shrestha
Publikováno v:
Future Oncology. 15:1493-1504
Aim: Evaluate duration of therapy among patients treated with afatinib or erlotinib as first-line therapy for non-small-cell lung cancer (NSCLC). Materials & methods: NSCLC patients initiating afatinib or erlotinib between 2014 and 2017 were identifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0aee294a6621f5bc7614c63f4697d9
https://doi.org/10.2217/fon-2019-0052
https://doi.org/10.2217/fon-2019-0052
Publikováno v:
Journal of managed carespecialty pharmacy. 26(10)
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most common adult leukemia, accounting for ≈ 37% of all leukemias in the United States. Limited real-word evidence is available on the outcomes of ibrutinib use among previous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80682659b417df22b4a67019e86f19e4
https://pubmed.ncbi.nlm.nih.gov/32880204
https://pubmed.ncbi.nlm.nih.gov/32880204
Autor:
Robyn M. Scherber, Jingbo Yu, Shreekant Parasuraman, Dilan Paranagama, Li Wang, Onur Baser, Sulena Shrestha
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
BMC Cancer
BMC Cancer
Background Polycythemia vera (PV) is a myeloproliferative neoplasm associated with increased thrombotic and cardiovascular risk, which are key contributors to patient morbidity and mortality. The Veterans Health Administration (VHA) is the largest in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c17b8c743a92a1c1ff154d357127a0e
http://link.springer.com/article/10.1186/s12885-018-4422-6
http://link.springer.com/article/10.1186/s12885-018-4422-6
Publikováno v:
Annals of Pharmacotherapy. 52:147-153
Non-vitamin K antagonist direct oral anticoagulants (DOACs) are fixed-dose regimens indicated for stroke prevention in nonvalvular atrial fibrillation (NVAF) patients. Dose adjustment is necessary among patients with renal insufficiency to optimize e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d44fe84de82a52d7ef729046f4581820
https://doi.org/10.1177/1060028017728295
https://doi.org/10.1177/1060028017728295
Publikováno v:
Advances in Therapy
Introduction Comparative data on the burden of atopic dermatitis (AD) in adults relative to the general population are limited. We performed a large-scale evaluation of the burden of disease among US adults with AD relative to matched non-AD controls
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d49d54277377cd1018a448122907d0
http://europepmc.org/articles/PMC5565673
http://europepmc.org/articles/PMC5565673
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-6 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-6 (2019)
New-onset heart failure (HF) is associated with cardiovascular morbidity and mortality. It is uncertain to what extent HF confers an increased risk of venous thromboembolism (VTE). Adults >= 65 years old hospitalized with a new diagnosis of HF were i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e5ccf7eb0d38f9d494cf47b107b209
https://pubmed.ncbi.nlm.nih.gov/31758003
https://pubmed.ncbi.nlm.nih.gov/31758003
Autor:
Robyn M. Scherber, Jingbo Yu, Onur Baser, Li Wang, Sulena Shrestha, Dilan Paranagama, Shreekant Parasuraman
Introduction: Patients with polycythemia vera (PV) have poor overall survival compared with the general population, with arterial and venous thrombotic events (TEs) representing a substantial source of morbidity and mortality. A subanalysis of the Cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c235feff1640fe1d8ce05a36dcca805e
https://hdl.handle.net/20.500.11779/1274
https://hdl.handle.net/20.500.11779/1274
Autor:
Ami Patel, Thomas Machnig, Joseph Chiao, Li Wang, Sulena Shrestha, Ellen Bonagua, Florence Ida Hsu, Sujana Borra, Marjorie C. Treadwell
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f83f1fb2b037bf9ae09279077710345
https://doi.org/10.1016/j.jaci.2019.12.629
https://doi.org/10.1016/j.jaci.2019.12.629